[The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
Antiarrhythmic treatment (AAT) adjusted to the variety of arrhythmia and risk to develop complications was given to 336 patients with ischemic heart disease associated with paroxysms of supraventricular tachycardia (SVT), atrial fibrillation or atrial flutter. In the presence of risk to develop AAT complications, the method of choice for SVT patients is transesophageal pacing and impulse therapy. In the presence of arrhythmic collapse, cardiac asthma and pulmonary edema it is preferable to correct arrhythmia by electric impulse therapy.
Andriushchenko
O M
OM
Olesin
A I
AI
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D001282:Atrial Flutter / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012307:Risk Factors; D013614:Tachycardia, Paroxysmal / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D013617:Tachycardia, Supraventricular / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents
Lechenie paroksizmal'nykh nadzheludochkovykh aritmiĭ u bol'nykh IBS s vysokim riskom razvitiia oslozhneniĭ antiaritmicheskoĭ terapii.